MedTrace Logo

Building Collaborations to Address Drug Problems in the United States and China

NCT04021030 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2022-04-07

No results posted yet for this study

Summary

The purpose of this study is to evaluate the impact of a Cognitive Behavioral Therapy (CBT) intervention on the distribution and variability of pain level before and after intervention receipt among people with co-occurring chronic pain and Substance Use Disorders (SUDs) over a three-month follow-up period.

Conditions

Interventions

BEHAVIORAL

Cognitive Behavioral Therapy (CBT)

The therapeutic intervention consists of 8, one-hour individual therapy sessions delivered over the course of 2 to 4 weeks with a trained CBT therapist. These sessions are designed to provide beneficial coping strategies that are helpful in dealing with both chronic pain and substance use.

Sponsors & Collaborators

  • Michigan Medicine - PKUHSC Joint Institute for Translational and Clinical Research

    collaborator UNKNOWN

  • Peking University

    collaborator OTHER

  • Meridian Health Services

    collaborator UNKNOWN

  • University of Michigan

    lead OTHER

Principal Investigators

  • Mark Ilgen, Ph.D. · University of Michigan

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-04
Primary Completion
2021-01-06
Completion
2021-01-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04021030 on ClinicalTrials.gov